Global pathogenomic analysis identifies known and candidate genetic antimicrobial resistance determinants in twelve species

Nat Commun. 2023 Nov 24;14(1):7690. doi: 10.1038/s41467-023-43549-9.

Abstract

Surveillance programs for managing antimicrobial resistance (AMR) have yielded thousands of genomes suited for data-driven mechanism discovery. We present a workflow integrating pangenomics, gene annotation, and machine learning to identify AMR genes at scale. When applied to 12 species, 27,155 genomes, and 69 drugs, we 1) find AMR gene transfer mostly confined within related species, with 925 genes in multiple species but just eight in multiple phylogenetic classes, 2) demonstrate that discovery-oriented support vector machines outperform contemporary methods at recovering known AMR genes, recovering 263 genes compared to 145 by Pyseer, and 3) identify 142 AMR gene candidates. Validation of two candidates in E. coli BW25113 reveals cases of conditional resistance: ΔcycA confers ciprofloxacin resistance in minimal media with D-serine, and frdD V111D confers ampicillin resistance in the presence of ampC by modifying the overlapping promoter. We expect this approach to be adaptable to other species and phenotypes.

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Ciprofloxacin / pharmacology
  • Drug Resistance, Bacterial / genetics
  • Escherichia coli* / genetics
  • Phylogeny

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin